← Open Payments lookup

VINCENT DUBESKY: Open Payments

NPI 1235878927 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,576 in 112 payments from 14 companies in 2025. Trend: 2023 $1,907 · 2024 $2,455 · 2025 $2,576

Food & beverage: $2,396Education: $180
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$486
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$429
E.R. Squibb & Sons, L.L.C.15$382
Neurocrine BioSciences, Inc.11$322
Otsuka America Pharmaceutical, Inc.13$229
Alkermes, Inc.6$209
ABBVIE INC.15$141
Axsome Therapeutics, Inc.6$133
Lundbeck LLC3$77
Supernus Pharmaceuticals, Inc.3$52

Products named: CAPLYTA, COBENFY, INGREZZA, LYBALVI, UZEDY, ABILIFY ASIMTUFII, VRAYLAR, REXULTI.

Industry payments across PA — which companies pay providers there.